Table 3.
Multivariable association between sclerostin and HbA1c for Mexican American men and women diagnosed with T2D.
| Variables | Men | Women | ||
|---|---|---|---|---|
| Adjusted mean difference (95% CI) | p value | Adjusted mean difference (95% CI) | p value | |
| HbA1c | ||||
| Age ≥ 65 group | 0.37 (−15.77, 16.50) | 0.96 | 2.52 (−0.24, 5.28) | 0.07 |
| Age < 65 group | −1.80 (−14.20, 10.60) | 0.72 | 2.45 (−0.19, 5.09) | 0.07 |
| BMI | −3.26 (−10.49, 3.96) | 0.30 | −0.93 (−1.73, −0.13) | 0.02 |
| Serum creatinine | −73.71 (−266.19, 118.77) | 0.37 | 29.05 (10.82, 47.29) | 0.003 |
| Serum calcium | −33.54 (−528.40, 461.31) | 0.87 | 0.15 (−48.80, 49.09) | 0.99 |
| Serum vitamin D | −0.96 (−2.56, 0.63) | 0.18 | 0.03 (−0.21, 0.27) | 0.82 |
| Femur neck BMD | 40.48 (−142.27, 223.22) | 0.59 | 94.31 (47.77, 140.87) | 0.0003 |
| ≥10 years since T2D diagnosis | 11.93 (−35.99, 59.84) | 0.55 | 4.43 (−4.49, 13.35) | 0.32 |
Note. CI: confidence interval; interaction effect between HbA1c and age for men p = 0.77, for women p = 0.29.